| AFP | α-fetoprotein |
| ALP | Alkaline phosphatase |
| BCLC | Barcelona clinic liver cancer |
| CR | Complete response |
| CT | Computed tomography |
| CTCAE | Common Toxicity Criteria for Adverse Events |
| CTV | Clinical target volume |
| DLT | Dose-limiting toxicity |
| ECOG | Eastern Cooperative Oncology Group |
| HCC | Hepatocellular carcinoma |
| IGRT | Image-guided radiotherapy |
| IMRT | Intensity-modulated radiotherapy |
| INR | International normalized ratio |
| IRB | Institutional Review Board |
| ITV | Internal target volume |
| OAR | Organs at risk |
| OS | Overall survival |
| PD | Progressive disease |
| PFS | Progression-free survival |
| PR | Partial response |
| PTV | Planning target volume |
| RILD | Radiation-induced liver disease |
| SBRT | Stereotactic body radiotherapy |
| SD | Stable disease |
| TACE | Transarterial chemoembolization |